Indirizzo: Via Portuense, 292     Telefono: +39 06.55170.1    

Menu

INMI Lazzaro Spallanzani
Istituto Nazionale Malattie Infettive

Menu principale

Pubblicazioni 2018

Produzione Scientifica 2018

  1. AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (Writing Group: … Antinori A…). Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS. 2018 Nov 28;32(18):2777-2786. doi: 10.1097/QAD.0000000000002003
  2. Albarello F, Cristofaro M, Busi Rizzi E, Giancola ML, Nicastri E, Schininà V. Pulmonary measles disease: old and new imaging tools. Radiol Med. 2018 Dec;123(12):935-943. Epub 2018 Jul 30. doi: 10.1007/s11547-018-0919-y
  3. Alberti A, Angarano G, Colombo M, Craxì A, Di Marco V, Di Perri G, Gaeta GB, Ippolito G, Mangia A, Pasqualetti P. Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experience. Clin Res Hepatol Gastroenterol. 2018 Oct 27. pii: S2210-7401(18)30189-X. [Epub ahead of print] doi: 10.1016/j.clinre.2018.09.007
  4. Alfonsi V, Romanò L, Ciccaglione AR, La Rosa G, Bruni R, Zanetti A, Della Libera S, Iaconelli M, Bagnarelli P, Capobianchi MR, Garbuglia AR, Riccardo F, Tosti ME, Collaborating Group. Hepatitis E in Italy: 5 years of national epidemiological, virological and environmental surveillance, 2012 to 2016. Euro Surveill. 2018 Oct;23(41). doi: 10.2807/1560-7917.ES.2018.23.41.1700517
  5. Alteri C, Fabeni L, Scutari R, Berno G, Di Carlo D, Gori C, Bertoli A, Vergori A, Mastrorosa I, Bellagamba R, Mussini C, Colafigli M, Montella F, Pennica A, Mastroianni CM, Girardi E, Andreoni M, Antinori A, Svicher V, Ceccherini-Silberstein F, Perno CFd, Santoro MM. Genetic divergence of HIV-1 B subtype in Italy over the years 2003-2016 and impact on CTL escape prevalence. Sci Rep. 2018 Oct 24;8(1):15739. doi: 10.1038/s41598-018-34058-7
  6. Ammassari A, Stöhr W, Antinori A, Molina JM, Schwimmer C, Domingo P, Thalme A, Di Pietro M, Wallet C, Pozniak A, Richert L, Raffi F; and the NEAT 001/ANRS 143 Trial Study Group. Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined with Either Raltegravir or Tenofovir Disoproxil Fumarate /Emtricitabine in the Neat 001/Anrs 143 Trial. J Acquir Immune Defic Syndr. 2018 Aug 27. [Epub ahead of print] doi: 10.1097/QAI.0000000000001834
  7. Andrade JM, Custódio L, Romagnoli A, Reis CP, Rodrigues MJ, Garcia C, Petruccioli E, Goletti D, Faustino C, Fimia GMd, Rijo P. Antitubercular and anti-inflammatory properties screening of natural products from Plectranthus species. Future Med Chem. 2018 Jul 1;10(14):1677-1691. Epub 2018 Jun 29. doi: 10.4155/fmc-2018-0043
  8. Andriulli A, Stroffolini T, Mariano A, Valvano MR, Grattagliano I, Ippolito AM, Grossi A, Brancaccio G, Coco C, Russello M, Smedile A, Petrini E, Martini S, Gaeta GB, Rizzetto M. Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas. Eur J Intern Med. 2018 Jul;53:79-84. Epub 2018 Feb 21. doi: 10.1016/j.ejim.2018.02.015
  9. Antinori A, Di Biagio A, Marcotullio S, Sarmati L, Andreoni M, Angarano G, Chirianni A, d’Arminio Monforte A, Di Perri G, Galli M, Gianotti N, Girardi E, Gori A, Mussini C, Perno CF, Lazzarin A. Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. New Microbiol. 2018 Oct;41(4):247-255.
  10. Antinori A, Lazzarin A, Uglietti A, Palma M, Mancusi D, Termini R. Efficacy and safety of boosted darunavir-based antiretroviral therapy in HIV-1-positive patients: results from a meta-analysis of clinical trials. Sci Rep. 2018 Mar 27;8(1):5288. doi: 10.1038/s41598-018-23375-6

    11. Armenia D, Zaccarelli M, Borghi V, Gennari W, Di Carlo D, Giannetti A, Forbici F, Bertoli A, Gori C, Fabeni L, Pinnetti C, Marocco R, Latini A, Ceccherini-Silberstein F, Mastroianni CM, Mussini C, Antinori A, Perno CF, Santoro MM. Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment. J Clin Virol. 2018 Jul;104:61-64. Epub 2018 Apr 3 doi: 10.1016/j.jcv.2018.04.001

  11. Baddley JW, Cantini F, Goletti D, Gómez-Reino JJ, Mylonakis E, San-Juan R, Fernández-Ruiz M, Torre-Cisneros J. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents). Clin Microbiol Infect. 2018 Jun;24 Suppl 2:S10-S20. Epub 2018 Feb 6. doi: 10.1016/j.cmi.2017.12.025
  12. Bassetti M, Castaldo N, Cattelan A, Mussini C, Righi E, Tascini C, Menichetti F, Mastroianni CM, Tumbarello M, Grossi P, Artioli S, Carrannante N, Cipriani L, Coletto D, Russo A, Digaetano M, Losito R, Peghin M, Capone A, Nicolè S, Vena A; CEFTABUSE study group. Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience. Int J Antimicrob Agents. 2018 Nov 8. pii: S0924-8579(18)30326-1. [Epub ahead of print] doi: 10.1016/j.ijantimicag.2018.11.001
  13. Battistelli C, Sabarese G, Santangelo L, Montaldo C, Gonzalez FJ, Tripodi Md, Cicchini C. The lncRNA HOTAIR transcription is controlled by HNF4α-induced chromatin topology modulation. Cell Death Differ. 2018 Aug 28. [Epub ahead of print] doi: 10.1038/s41418-018-0170-z
  14. Becher J, Simula L, Volpe E, Procaccini C, La Rocca C, D’Acunzo P, Cianfanelli V, Strappazzon F, Caruana I, Nazio F, Weber G, Gigantino V, Botti G, Ciccosanti F, Borsellino G, Campello S, Mandolesi G, De Bardi M, Fimia GMd, D’Amelio M, Ruffini F, Furlan R, Centonze D, Martino G, Braghetta P, Chrisam M, Bonaldo P, Matarese G, Locatelli F, Battistini L, Cecconi F. AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis. Dev Cell. 2018 Dec 3;47(5):592-607.e6. doi: 10.1016/j.devcel.2018.11.010
  15. Biliotti E, Franchi C, Spaziante M, Garbuglia AR, Volpicelli L, Palazzo D, De Angelis M, Esvan R, Taliani G. Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin. Infection. 2018 Oct;46(5):725-727. Epub 2018 Jun 26. doi: 10.1007/s15010-018-1168-7
  16. Blauenfeldt T, Petrone L, Del Nonno F, Baiocchini A, Falasca L, Chiacchio T, Bondet V, Vanini V, Palmieri F, Galluccio G, Casrouge A, Eugen-Olsen J, Albert ML, Goletti D, Duffy D, Ruhwald M. Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions. Front Immunol. 2018 Jul 5;9:1456. eCollection 2018. doi: 10.3389/fimmu.2018.01456
  17. Borderi M, Angarano G, Antinori A, Chirianni A, Cinque P, D’Arminio Monforte A, Di Biagio A, Di Perri G, Galli M, Gori A, Lazzarin A, Mussini C, Perno CF, Quirino T, Rizzardini G, Calza L, Viale P, Acone B, Andreoni M. Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment. New Microbiol. 2018 Apr;41(2):112-117.
  18. Bordi L, Carletti F, Lalle E, Colavita F, Meschi S, Di Caro A, Nicastri E, Scognamiglio P, Vairo F, Di Lallo D, Panella V, Capobianchi MR, Ippolito G, Castilletti C. Molecular Characterization of Autochthonous Chikungunya Cluster in Latium Region, Italy. Emerg Infect Dis. 2018 Jan;24(1). Epub 2018 Jan 17. doi: 10.3201/eid2401.171605
  19. Bordoni V, Viola D, Sacchi A, Pinnetti C, Casetti R, Cimini E, Tumino N, Antinori A, Ammassari A, Agrati C. IL-18 and Stem Cell Factor affect hematopoietic progenitor cells in HIV-infected patients treated during primary HIV infection. Cytokine. 2018 Mar;103:34-37. Epub 2018 Jan 8. doi: 10.1016/j.cyto.2017.12.033
  20. Boumis E, Capone A, Galati V, Venditti C, Petrosillo N. Probiotics an infective endocarditis in patients with hereditary hemorrhagic telangiectasia: a clinical case and a of the literature. BMC Infect Dis. 2018 Feb 1;18(1):65. doi: 10.1186/s12879-018-2956-5
  21. Bozorgmehr K, Samuilova M, Petrova-Benedict R, Girardi E, Piselli P, Kentikelenis A. Infectious disease health services for refugees and asylum seekers during a time of crisis: A scoping study of six European Union countries. Health Policy. 2018 Apr 11. pii: S0168-8510(18)30079-4. [Epub ahead of print] doi: 10.1016/j.healthpol.2018.04.003
  22. Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR,Pappa K, Wynne B, Fettiplace A, Gartland M, Aboud M, Smith K; GEMINI Study Team. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials. Lancet. 2018 Nov 9. pii: S0140-6736(18)32462-0. [Epub ahead of print] doi: 10.1016/S0140-6736(18)32462-0
  23. Calcagno A, Pinnetti C, De Nicolò A, Scarvaglieri E, Gisslen M, Tempestilli M, D’Avolio A, Fedele V, Di Perri G, Antinori A, Bonora S. Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration. Br J Clin Pharmacol. 2018 Jun;84(6):1380-1383. Epub 2018 Mar 15. doi: 10.1111/bcp.13552
  24. Cannas A, Camassa S, Sali M, Butera O, Mazzarelli A, Sanguinetti M, Di Caro A, Delogu G, Girardi E. Genetic Diversity of Mycobacterium tuberculosis Isolates in the Metropolitan Area of Rome. Chemotherapy. 2018 Jun 14;63(3):148-154. [Epub ahead of print] doi: 10.1159/000489860
  25. Caro-Vega Y, Schultze A, W Efsen AM, Post FA, Panteleev A, Skrahin A, Miro JM, Girardi E, Podlekareva DN, Lundgren JD, Sierra-Madero J, Toibaro J, Andrade-Villanueva J, Tetradov S, Fehr J, Caylà J, Losso MH, Miller RF, Mocroft A, Kirk O, Crabtree-Ramírez B. Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America. BMC Infect Dis. 2018 Apr 23;18(1):191. doi: 10.1186/s12879-018-3077-x
  26. Cartocci V, Catallo M, Tempestilli M, Segatto M, Pfrieger FW, Bronzuoli MR, Scuderi C, Servadio M, Trezza V, Pallottini V. Altered Brain Cholesterol/Isoprenoid Metabolism in a Rat Model of Autism Spectrum Disorders. Neuroscience. 2018 Feb 21;372:27-37. Epub 2018 Jan 6. doi: 10.1016/j.neuroscience.2017.12.053
  27. Carvalho I, Goletti D, Manga S, Silva DR, Manissero D, Migliori G. Managing latent tuberculosis infection and tuberculosis in children. Rev Port Pneumol (2006). 2018 Mar-Apr;24(2):106-114. Epub 2018 Mar 2. doi: 10.1016/j.rppnen.2017.10.007
  28. Castillo JJ, Guerrero-Garcia T, Baldini F, Tchernonog E, Cartron G, Ninkovic S, Cwynarski K, Dierickx D, Tousseyn T, Lansigan F, Linnik Y, Mogollon R, Navarro JT, Olszewski AJ, Reagan JL, Fedele P, Gilbertson M, Grigoriadis G, Bibas M. Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma. Br J Haematol. 2018 Mar 12. [Epub ahead of print] doi: 10.1111/bjh.15156
  29. Ceccherini-Silberstein F, Cozzi Lepri A, Alteri C, Merlini E, Surdo M, Marchetti G, Capobianchi MR, De Luca A, Gianotti N, Viale P, Andreoni M, Antinori A, Perno CFd, d’Arminio Monforte A; ICONA Foundation Study Group. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART. J Antimicrob Chemother. 2018 Dec 1;73(12):3460-3470. doi: 10.1093/jac/dky350
  30. Chiacchio T, Petruccioli E, Vanini V, Cuzzi G, La Manna MP, Orlando V, Pinnetti C, Sampaolesi A, Antinori A, Caccamo N, Goletti D. Impact of antiretroviral and tuberculosis therapies on CD4(+) and CD8(+) HIV/M. tuberculosis-specific T-cell in co-infected subjects. Immunol Lett. 2018 Jun;198:33-43. Epub 2018 Apr 7. doi: 10.1016/j.imlet.2018.04.001
  31. Colavita F, Bordoni V, Caglioti C, Biava M, Castilletti C, Bordi L, Quartu S, Iannetta M, Ippolito G, Agrati C, Capobianchi MR, Lalle E. ZIKV Infection Induces an Inflammatory Response but Fails to Activate Types I, II, and III IFN Response in Human PBMC. Mediators Inflamm. 2018 Jun 3;2018:2450540. eCollection 2018. doi: 10.1155/2018/2450540
  32. Colavita F, Musumeci G, Caglioti C. Human Osteoblast-like Cells Are Permissive for Zika Virus Replication. J Rheumatol. 2018 Mar;45(3):443. doi: 10.3899/jrheum.170835
  33. Colavita F, Vita S, Lalle E, Carletti F, Bordi L, Vincenti D, Pozzetto I, Aiuti M, Vairo F, Capobianchi MR, Lichtner M, Castilletti C. Overproduction of IL-6 and Type-I IFN in a Lethal Case of Chikungunya Virus Infection in an Elderly Man During the 2017 Italian Outbreak. Open Forum Infect Dis. 2018 Oct 25;5(11):ofy276. eCollection 2018 Nov. doi: 10.1093/ofid/ofy276
  34. Colson P, Capobianchi MR. International Journal of Antimicrobial Agents Themed Section Issue: “Therapeutics of hepatitis viruses”. Int J Antimicrob Agents. 2018 Mar 21. pii: S0924-8579(18)30082-7. [Epub ahead of print] doi: 10.1016/j.ijantimicag.2018.03.011
  35. Concia E, Viscoli C, Del Bono V, Giannella M, Bassetti M, De Rosa GF, Durante Mangoni E, Esposito S, Giusti M, Grossi P, Menichetti F, Pea F, Petrosillo N, Tumbarello M, Stefani S, Venditti M, Viale P; group of Italian Experts. The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts. J Chemother. 2018; 30(3):157-171 Epub 2018 Jan 30 doi: 10.1080/1120009X.2017.1420610
  36. Cucchiarelli S, Santopaolo F, Lamazza A, Lionetti R, Lenci I, Manzia TM, Angelico M, Milana M, Baiocchi L. Pitfalls in the reporting of upper endoscopy features in cirrhotic patients. Dig Liver Dis. 2018 Aug 18. pii: S1590-8658(18)30895-8. [Epub ahead of print] doi: 10.1016/j.dld.2018.08.014
  37. D’Abramo A, Gebremeskel Tekle S, Iannetta M, Scorzolini L, Oliva A, Paglia MG, Corpolongo A, Nicastri E. Severe Plasmodium ovale malaria complicated by acute respiratory distress syndrome in a young Caucasian man. Malar J. 2018 Apr 2;17(1):139. doi: 10.1186/s12936-018-2289-2
  38. d’Arminio Monforte A, Diaz-Cuervo H, De Luca A, Maggiolo F, Cingolani A, Bonora S, Castagna A, Girardi E, Antinori A, Lo Caputo S, Guaraldi G, Cozzi-Lepri A; ICONA Foundation Study Group. Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014. HIV Med. 2018 Nov 21. [Epub ahead of print] doi: 10.1111/hiv.12683
  39. d’Arminio Monforte A, Lorenzini P, Cozzi-Lepri A, Mussini C, Castagna A, Baldelli F, Puoti M, Vichi F, Maddaloni A, Lo Caputo S, Gianotti N, Antinori A; on behalf of the Icona Foundation Study Group. Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort(). HIV Clin Trials. 2018 Apr;19(2):52-60. Epub 2018 Mar 1. doi: 10.1080/15284336.2018.1440691
  40. De Maio F, Battah B, Palmieri V, Petrone L, Corrente F, Salustri A, Palucci I, Bellesi S, Papi M, Rubino S, Sali M, Goletti D, Sanguinetti M, Manganelli R, De Spirito M, Delogu G. PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis. Cell Microbiol. 2018 Dec;20(12):e12952. Epub 2018 Sep 26. doi: 10.1111/cmi.12952
  41. De Maio F, Squeglia F, Goletti D, Delogu G. The Mycobacterial HBHA Protein: a Promising Biomarker for Tuberculosis. Curr Med Chem. 2018 Oct 29. [Epub ahead of print] doi: 10.2174/0929867325666181029165805
  42. De Nardo Pd, Gentilotti E, Vairo F, Nguhuni Bd, Chaula Z, Nicastri E, Ismail A, Ippolito G. A retrospective evaluation of bites at risk of rabies transmission across 7 years: The need to improve surveillance and reporting systems for rabies elimination. PLoS One. 2018 Jul 2;13(7):e0197996. eCollection 2018. doi: 10.1371/journal.pone.0197996
  43. D’Eletto M, Rossin F, Fedorova O, Farrace MG, Piacentini Md. Transglutaminase type 2 in the regulation of proteostasis. Biol Chem. 2018 Jun 20. pii: /j/bchm.ahead-of-print/hsz-2018-0217/hsz-2018-0217.xml. [Epub ahead of print]. doi: 10.1515/hsz-2018-0217
  44. D’Eletto M, Rossin F, Occhigrossi L, Farrace MG, Faccenda D, Desai R, Marchi S, Refolo G, Falasca L, Antonioli M, Ciccosanti F, Fimia GMd, Pinton P, Campanella M, Piacentini Md. Transglutaminase Type 2 Regulates ER-Mitochondria Contact Sites by Interacting with GRP75. Cell Rep. 2018 Dec 26;25(13):3573-3581.e4. doi: 10.1016/j.celrep.2018.11.094
  45. Dentone C, Di Biagio A, Cozzi Lepri A, Fenoglio D, Filaci G, Lichtner M, Carrara S, Giacometti A, Sighinolfi L, Marchetti G, Antinori A, D’arminio Monforte A; ICONA Foundation Study Group. Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients. HIV Clin Trials. 2018 Aug;19(4):158-162. 2018 Nov 13. doi: 10.1080/15284336.2018.1488453
  46. Di Marco V, Alberti A, Angarano G, Colombo M, Di Perri G, Gaeta GB, Ippolito G, Mangia A, Pasqualetti P, Craxì A. Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus. Eur Rev Med Pharmacol Sci. 2018 Oct;22(20):7024-7033. doi: 10.26355/eurrev_201810_16174
  47. di Masi A, Leboffe L, Polticelli F, Tonon F, Zennaro C, Caterino M, Stano P, Fischer S, Hägele M, Müller M, Kleger A, Papatheodorou P, Nocca G, Arcovito A, Gori A, Ruoppolo M, Barth H, Petrosillo N, Ascenzi P, Di Bella S. Human Serum Albumin Is an Essential Component of the Host Defense Mechanism Against Clostridium difficile Intoxication. J Infect Dis. 2018 Sep 22;218(9):1424-1435. doi: 10.1093/infdis/jiy338
  48. Donà MG, Benevolo M, Latini A, Rollo F, Colafigli M, Frasca M, Zaccarelli M, Giglio A, Moretto D, Pescarmona E, Cristaudo A, Giuliani M. Anal cytological lesions and HPV infection in individuals at increased risk for anal cancer. Cancer Cytopathol. 2018 Apr 25. [Epub ahead of print] doi: 10.1002/cncy.22003
  49. Drgona L, Gudiol C, Lanini S, Salzberger B, Ippolito G, Mikulska M. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4). Clin Microbiol Infect. 2018 Jun;24 Suppl 2:s83-s94. Epub 2018 Mar 20. doi: 10.1016/j.cmi.2018.03.022
  50. Eron JJ, Orkin C, Gallant J, Molina JM, Negredo E, Antinori A, Mills A, Reynes J, Van Landuyt E, Lathouwers E, Hufkens V, Jezorwski J, Vanveggel S, Opsomer M; AMBER study group. A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients. AIDS. 2018 Jul 17;32(11):1431-1442. doi: 10.1097/QAD.0000000000001817
  51. Errico G, Gagliotti C, Monaco M, Masiero L, Gaibani P, Ambretti S, Landini MP, D’Arezzo S, Di Caro A, Parisi SG, Palù G, Vespasiano F, Morsillo F, Moro ML, Procaccio F, Ricci A, Grossi PA, Pantosti A, Costa AN; SInT Collaborative Study Group. Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy. Clin Microbiol Infect. 2018 May 22. pii: S1198-743X(18)30409-9. [Epub ahead of print] doi: 10.1016/j.cmi.2018.05.003
  52. Etna MP, Sinigaglia A, Grassi A, Giacomini E, Romagnoli A, Pardini M, Severa M, Cruciani M, Rizzo F, Anastasiadou E, Di Camillo B, Barzon L, Fimia GMd, Manganelli R, Coccia EM. Mycobacterium tuberculosis-induced miR-155 subverts autophagy by targeting ATG3 in human dendritic cells. PLoS Pathog. 2018 Jan 4;14(1):e1006790. eCollection 2018 Jan. doi: 10.1371/journal.ppat.1006790
  53. Fabbiani M, Gagliardini R, Ciccarelli N, Quiros Roldan E, Latini A, d’Ettorre G, Antinori A, Castagna A, Orofino G, Francisci D, Chinello P, Madeddu G, Grima P, Rusconi S, Del Pin B, Lombardi F, D’Avino A, Focà E, Colafigli M, Cauda R, Di Giambenedetto S, De Luca A; ATLAS-M Study Group. Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. J Antimicrob Chemother. 2018;73(7):1955-1964 doi: 10.1093/jac/dky123
  54. Fabbri G, Mastrorosa I, Vergori A, Timelli L, Lorenzini P, Zaccarelli M, Cicalini S, Bellagamba R, Plazzi MM, Mazzotta V, Antinori A, Ammassari A. Liver stiffness reduction and serum fibrosis score improvement in HIV/hepatitis C virus-coinfected patients treated with direct-acting antivirals. HIV Med. 2018;19(8):578-584 doi: 10.1111/hiv.12632
  55. Falcone M, Tiseo G, Iraci F, Raponi G, Goldoni P, Delle Rose D, Santino I, Carfagna P, Murri R, Fantoni M, Fontana C, Sanguinetti M, Farcomeni A, Antonelli G, Aceti A, Mastroianni C, Andreoni M, Cauda R, Petrosillo N, Venditti M. Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes. Clin Microbiol Infect. 2018 Jun 28. pii: S1198-743X(18)30485-3. [Epub ahead of print] doi: 10.1016/j.cmi.2018.06.020
  56. Fania L, Ruggeri S, Sordi D, Oliva A, Provini A, Ricci F, Mazzanti C. Sweet syndrome following a positive Mantoux test due to pulmonary tuberculosis. Dermatol Ther. 2018 Sep 20:e12754. [Epub ahead of print] doi: 10.1111/dth.12754
  57. Floridia M, Pinnetti C, Ravizza M, Masuelli G, Personeni C, Sansone M, Antoni AD, Guaraldi G, Spinillo A, Tassis B, Dalzero S, Liuzzi G, Tamburrini E; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy. Abacavir/Lamivudine and Tenofovir/Emtricitabine in Pregnant Women with Hiv: Laboratory and Clinical Outcomes in an Observational National Study. J Acquir Immune Defic Syndr. 2018 May 1;78(1):99-104. doi: 10.1097/QAI.0000000000001640
  58. Fokam J, Bellocchi MC, Armenia D, Nanfack AJ, Carioti L, Continenza F, Takou D, Temgoua ES, Tangimpundu C, Torimiro JN, Koki PN, Fokunang CN, Cappelli G, Ndjolo A, Colizzi V, Ceccherini-Silberstein F, Perno CF, Santoro MM. Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children. Medicine (Baltimore). 2018 Mar;97(13):e0176. doi: 10.1097/MD.0000000000010176
  59. Franzetti M, De Luca A, Ceccherini-Silberstein F, Spagnuolo V, Nicastri E, Mussini C, Antinori A, Monno L, Vecchiet J, Fanti I, d’Arminio Monforte A, Balotta C; ICONA Foundation Study Group. Evolution of HIV-1 transmitted drug resistance in Italy in the 2007-2014 period: A weighted analysis. J Clin Virol. 2018 Sep;106:49-52. Epub 2018 Jul 26. doi: 10.1016/j.jcv.2018.07.009
  60. Frustaci Ad, De Luca A, Guida V, Biagini T, Mazza T, Gaudio C, Letizia C, Russo MA, Galea N, Chimenti Cd. Novel α-Actin Gene Mutation p.(Ala21Val) Causing Familial Hypertrophic Cardiomyopathy, Myocardial Noncompaction, and Transmural Crypts. Clinical-Pathologic Correlation. J Am Heart Assoc. 2018 Feb 10;7(4). pii: e008068. doi: 10.1161/JAHA.117.008068
  61. Frustaci Ad, Placanica G, Galea N, Chimenti Cd. Auto-Reactive Myocarditis and Necrotizing Coronary Vasculitis After Blunt Chest Trauma. Circ Cardiovasc Imaging. 2018 Sep;11(9):e008078. doi: 10.1161/CIRCIMAGING.118.008078
  62. Frustaci Ad, Verardo R, Grande C, Galea N, Piselli P, Carbone I, Alfarano M, Russo MA, Chimenti Cd. Immune-Mediated Myocarditis in Fabry Disease Cardiomyopathy. J Am Heart Assoc. 2018 Sep 4;7(17):e009052. doi: 10.1161/JAHA.118.009052
  63. Fusco C, Mandriani B, Di Rienzo Md, Micale L, Malerba N, Cocciadiferro D, Sjøttem E, Augello B, Squeo G, Pellico MT, Jain A, Johansen T, Fimia GMd, Merla G. TRIM50 regulates Becli-1 proautophagic activity. Biochim Biophys Acta. 2018 Jun;1865(6):908-919. Epub Mar 29. doi: 10.1016/j.bbamcr.2018.03.011
  64. Gaeta GB, Aghemo A, Menzaghi B, D’Offizi G, Giorgini A, Hasson H, Brancaccio G, Palma M, Termini R; STIly Study Group. Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy: The STIly observational study. Medicine (Baltimore). 2018 Jul;97(27):e11307. doi: 10.1097/MD.0000000000011307
  65. Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D’Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GMd, Fulda S, García-Sáez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jäättelä M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Muñoz-Pinedo C, Nagata S, Nuñez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini Md, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018 Mar;25(3):486-541. Epub 2018 Jan 23. doi: 10.1038/s41418-017-0012-4
  66. Gebremeskel Tekle S, Corpolongo A, D’Abramo A, Giancola ML, Iannetta M, Scorzolini L, Marcozzi P, Buffone E, Liuzzi G, Nicastri E. Case Report: Delayed Diagnosis of Congenital Malaria by Plasmodium vivax in a Newborn of an Eritrean Woman with Varicella Infection. Am J Trop Med Hyg. 2018 Sep;99(3):620-622. Epub 2018 Jul 12. doi: 10.4269/ajtmh.18-0091
  67. Giancola ML, Balestra P, Ammassari A, Ricottini M, Lorenzini P, Angeletti C, Bellagamba R, Tommasi C, Tempestilli M, Zaccarelli M, Pinnetti C, Gallo AL, Antinori A, Narciso P, Nicastri E. Prevalence and Associated Factors of Neurocognitive Impairment in HIV-Positive Patients on Effective Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Treatment. AIDS Res Hum Retroviruses. 2018 Nov;34(11):907-908. Epub 2018 Jul 23. doi: 10.1089/AID.2018.0074
  68. Giglio P, Gagliardi M, Bernardini R, Mattei M, Cotella D, Santoro C, Piacentini Md, Corazzari M. Ecto-Calreticulin is essential for an efficient immunogenic cell death stimulation in mouse Melanoma. Genes Immun. 2018 Oct 4. [Epub ahead of print] doi: 10.1038/s41435-018-0047-7
  69. Giglio Pd, Gagliardi M, Tumino N, Antunes F, Smaili S, Cotella D, Santoro C, Bernardini R, Mattei M, Piacentini Md, Corazzari Md. PKR and GCN2 stress kinases promote an ER stress-independent eIF2α phosphorylation responsible for calreticulin exposure in melanoma cells. Oncoimmunology. 2018 May 31;7(8):e1466765. eCollection 2018. doi: 10.1080/2162402X.2018.1466765
  70. Giuliani M, Latini A, Colafigli M, Benevolo M, Rollo F, Zaccarelli M, Giuliani E, Moretto D, Giglio A, Rezza G, Cristaudo A, Donà MG. Vaccine-preventable anal infections by human papillomavirus among HIV-infected men who have sex with men. Future Microbiol. 2018 Oct;13:1463-1472. Epub 2018 Oct 12. doi: 10.2217/fmb-2018-0149
  71. Goletti D, Lee MR, Wang JY, Walter N, Ottenhoff THM. Update on tuberculosis biomarkers: From correlates of risk, to correlates of active disease and of cure from disease. Respirology. 2018 May;23(5):455-466. Epub 2018 Feb 18. doi: 10.1111/resp.13272
  72. Goletti D, Lindestam Arlehamn CS, Scriba TJ, Anthony R, Cirillo DM, Alonzi T, Denkinger CM, Cobelens F. Can we predict tuberculosis cure? What tools are available? Eur Respir J. 2018 Nov 8;52(5). pii: 1801089. Print 2018 Nov. doi: 10.1183/13993003.01089-2018
  73. Goletti D, Petrone L, Ippolito G, Niccoli L, Nannini C, Cantini F. Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs. Expert Rev Anti Infect Ther. 2018 Jun;16(6):501-512. Epub 2018 Jun 12. doi: 10.1080/14787210.2018.1483238
  74. Gruber CEM, Giombini E, Selleri M, Tausch SH, Andrusch A, Tyshaieva A, Cardeti G, Lorenzetti R, De Marco L, Carletti F, Nitsche A, Capobianchi MR, Ippolito G, Autorino GL, Castilletti C. Whole Genome Characterization of Orthopoxvirus (OPV) Abatino, a Zoonotic Virus Representing a Putative Novel Clade of Old World Orthopoxviruses. Viruses. 2018 Oct 6;10(10). pii: E546. doi: 10.3390/v10100546
  75. Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Magis-Escurra C, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C; for TBNET. Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries. Am J Respir Crit Care Med. 2018 Aug 1;198(3):379-386. doi: 10.1164/rccm.201710-2141OC
  76. IeDEA and COHERE Cohort Collaborations (… Antinori A …). Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clin Infect Dis. 2018 Mar 5;66(6):893-903. doi: 10.1093/cid/cix915
  77. Ingle SM, Crane HM, Glass TR, Yip B, Lima VD, Gill MJ, Hanhoff N, Ammassari A, Mugavero MJ, Tate JP, Guest J, Turner NL, May MT, Sterne JAC. Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration. J Clin Med. 2018 Oct 5;7(10). pii: E328. doi: 10.3390/jcm7100328
  78. Ippolito G, Zumla A, Lanini S. Is there sufficient evidence to repeal three decades of clinical research on chronic hepatitis C? Clin Microbiol Infect. 2018 Apr;24(4):328-331. Epub Jan 8. doi: 10.1016/j.cmi.2018.01.001
  79. Kik SV, Schumacher S, Cirillo DM, Churchyard G, Boehme C, Goletti D, Rangaka MX, Denkinger CM, Lienhardt C, Gilpin C, Matteelli A, Cobelens F. An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease. Eur Respir J. 2018 Oct 25;52(4). pii: 1800946. Print 2018 Oct. doi: 10.1183/13993003.00946-2018
  80. Lalle E, Colavita F, Iannetta M, Gebremeskel Teklè S, Carletti F, Scorzolini L, Bordi L, Vincenti D, Castilletti C, Ippolito G, Capobianchi MR, Nicastri E. Prolonged detection of dengue virus RNA in the semen of a man returning from Thailand to Italy, January 2018. Euro Surveill. 2018 May;23(18). doi: 10.2807/1560-7917.ES.2018.23.18.18-00197
  81. Langer M, Portella G, Finazzi S, Chatenoud L, Lanini S, Vairo F, Fowler R, Miccio R, Ippolito G, Bertolini G, Strada G. Intensive care support and clinical outcomes of patients with Ebola virus disease (EVD) in West Africa. Intensive Care Med. 2018 Aug;44(8):1266-1275. Epub 2018 Jul 30. doi: 10.1007/s00134-018-5308-4
  82. Lanini S, Pisapia R, Capobianchi MR, Ippolito G. Global epidemiology of viral hepatitis and national needs for complete control. Expert Rev Anti Infect Ther. 2018 Aug;16(8):625-639. Epub 2018 Aug 2. doi: 10.1080/14787210.2018.1505503
  83. Lanini S, Scognamiglio P, Mecozzi A, Lombardozzi L, Vullo V, Angelico M, Gasbarrini A, Taliani G, Attili AF, Perno CF, De Santis A, Puro V, Cerqua F, D’Offizi G, Pellicelli A, Armignacco O, Mennini FS, Siciliano M, Girardi E, Panella V, Ippolito G; members of the Lazio Region HCV treatment group. Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study. BMC Infect Dis. 2018 May 16;18(1):223. doi: 10.1186/s12879-018-3125-6
  84. Lanini S, Scognamiglio P, Pisapia R, Minosse C, Agresta A, Ippolito G. Recovery of metabolic impairment of patients who cleared HCV infections after direct-acting antiviral therapy. Int J Antimicrob Agents. 2018 Dec 11. pii: S0924-8579(18)30363-7. [Epub ahead of print] doi: 10.1016/j.ijantimicag.2018.11.024
  85. Lubbers R, Sutherland J, Goletti D, de Paus RA, Van Moorsel CH, VeltkampM, Vestjens SM, Bos WJ, Petrone L, Del Nonno F, Bajema IM, Dijkman K, Verreck FA, Walzl G, Gelderman KA, Groeneveld GH, Geluk A, Ottenhoff TH, Joosten SA, Trouw LA. Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis. Front Immunol. 2018 Oct 23;9:2427. eCollection 2018 doi: 10.3389/fimmu.2018.02427
  86. Martins I, Raza SQ, Voisin L, Dakhli H, Allouch A, Law F, Sabino D, De Jong D, Thoreau M, Mintet E, Dugué D, Piacentini Md, Gougeon ML, Jaulin F, Bertrand P, Brenner C, Ojcius DM, Kroemer G, Modjtahedi N, Deutsch E, Perfettini JL. Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death. Cell Death Dis. 2018 Jun 18;9(7):716. doi: 10.1038/s41419-018-0747-y
  87. Mascia C, Pozzetto I, Kertusha B, Marocco R, Del Borgo C, Tieghi T, Vita S, Savinelli S, Iannetta M, Vullo V, Lichtner M, Mastroianni CM. Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection. PLoS One. 2018 May 24;13(5):e0198174. eCollection 2018. doi: 10.1371/journal.pone.0198174
  88. Masetti C, Lionetti R, Lupo M, Siciliano M, Giannelli V, Ponziani FR, Teti E, Dell’Unto C, Francioso S, Brega A, Montalbano M, Visco-Comandini U, Taibi C, Galati G, Vespasiani Gentilucci U, Picardi A, Andreoni M, Pompili M, Pellicelli AM, D’Offizi G, Gasbarrini A, De Santis A, Angelico M. Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis. J Viral Hepat. 2018 Dec;25(12):1493-1500. Epub 2018 Sep 6. doi: 10.1111/jvh.12982
  89. Menzo S, Minosse C, Vincenti D, Vincenzi L, Iacomi F, Zaccaro P, D’Offizi G, Capobianchi MR. Long-Term Follow-Up of Acute Hepatitis B: New Insights in Its Natural History and Implications for Antiviral Treatment. Genes (Basel). 2018 Jun 12;9(6). pii: E293. doi: 10.3390/genes9060293
  90. Migliori GB, Sotgiu G, Rosales-Klintz S, Centis R, D’Ambrosio L, Abubakar I, Bothamley G, Caminero JA, Cirillo DM, Dara M, de Vries G, Aliberti S, Dinh-Xuan AT, Duarte R, Midulla F, Solovic I, Subotic D, Amicosante M, Correira AM, Cirule A, Gualano G, Kunst H, Palmieri F, Riekstina V, Tiberi S, Verduin R, van der Werf MJ. ERS/ECDC Statement: European Union Standards for Tuberculosis Care – 2017 update. Eur Respir J. 2018 May;51(5). pii: 1702678. Print 2018 May. doi: 10.1183/13993003.02678-2017
  91. Mikulska M, Lanini S, Gudiol C, Drgona L, Ippolito G, Fernández-Ruiz M, Salzberger B. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52). Clin Microbiol Infect. 2018 Jun; 24 Suppl 2:s71-s82. Epub 2018 Feb 12 doi: 10.1016/j.cmi.2018.02.003
  92. Minosse C, Selleri M, Giombini E, Bartolini B, Capobianchi MR, Cerilli S, Loiacono L, Taibi C, D’Offizi G, McPhee F, Garbuglia A. Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents. Infect Drug Resist. 2018 Nov 2;11:2117-2127. eCollection 2018. doi: 10.2147/IDR.S179158
  93. Mussini C, Lorenzini P, Cozzi-Lepri A, Marchetti G, Rusconi S, Gori A, Nozza S, Lichtner M, Antinori A, Cossarizza A, d’Arminio Monforte A; Icona Foundation Study Group. Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study. BMC Med. 2018 May 29;16(1):79. doi: 10.1186/s12916-018-1046-2.
  94. Niccoli L, Nannini C, Blandizzi C, Mantarro S, Mosca M, Di Munno O, Goletti D, Benucci M, Gobbi FL, Cassarà E, Kaloudi O, Cantini F. Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables. Ther Clin Risk Manag. 2018 Oct 24;14:2097-2111. eCollection 2018. doi: 10.2147/TCRM.S175772
  95. Orlando V, La Manna MP, Goletti D, Palmieri F, Lo Presti E, Joosten SA, La Mendola C, Buccheri S, Ottenhoff THM, Dieli F, Caccamo N. Human CD4 T-Cells With a Naive Phenotype Produce Multiple Cytokines During Mycobacterium Tuberculosis Infection and Correlate With Active Disease. Front Immunol. 2018 May 23;9:1119. eCollection 2018. doi: 10.3389/fimmu.2018.01119
  96. Pane S, Giancola ML, Piselli P, Corpolongo A, Repetto E, Bellagamba R, Cimaglia C, Carrara S, Ghirga P, Oliva A, Bevilacqua N, Al Rousan A, Nisii C, Ippolito G, Nicastri E. Serological evaluation for Chagas disease in migrants from Latin American countries resident in Rome, Italy. BMC Infect Dis. 2018 May 8;18(1):212. doi: 10.1186/s12879-018-3118-5
  97. Paolino M, Brindisi M, Vallone A, Butini S, Campiani G, Nannicini C, Giuliani G, Anzini M, Lamponi S, Giorgi G, Sbardella D, Ferraris DM, Marini S, Coletta M, Palucci I, Minerva M, Delogu G, Pepponi I, Goletti D, Cappelli A, Gemma S, Brogi S. Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages. ChemMedChem. 2018 Mar 6; 13(5):422-430. Epub 2018 Feb 14. doi: 10.1002/cmdc.201700759
  98. Parlato S, Chiacchio T, Salerno D, Petrone L, Castiello L, Romagnoli G, Canini I, Goletti D, Gabriele L. Impaired IFN-α-mediated signal in dendritic cells differentiates active from latent tuberculosis. PLoS One. 2018 Jan 10;13(1):e0189477. eCollection 2018. doi: 10.1371/journal.pone.0189477
  99. Petersen E, Abubakar I, Ihekweazu C, Heymann D, Ntoumi F, Blumberg L, Asogun D, Mukonka V, Lule SA, Bates M, Honeyborne I, Mfinanga S, Mwaba P, Dar O, Vairo F, Mukhtar M, Kock R, McHugh T, Ippolito G, Zumla A. Monkeypox – Enhancing Public Health Preparedness for an Emerging Lethal Human Zoonotic Epidemic Threat in the Wake of the Smallpox Post-Eradication Era. Int J Infect Dis. 2018 Nov 16. pii: S1201-9712(18)34587-9. [Epub ahead of print] doi: 10.1016/j.ijid.2018.11.008
  100. Petrone L, Bondet V, Vanini V, Cuzzi G, Palmieri F, Palucci I, Delogu G, Ciccosanti F, Fimia GMd, Blauenfeldt T, Ruhwald M, Duffy D, Goletti D. First description of agonist and antagonist IP-10 in urine of patients with active TB. Int J Infect Dis. 2018 Sep 7. pii: S1201-9712(18)34513-2. [Epub ahead of print] doi: 10.1016/j.ijid.2018.09.001
  101. Petrone L, Vanini V, Chiacchio T, Petruccioli E, Cuzzi G, Schininà V, Palmieri F, Ippolito G, Goletti D. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection. Tuberculosis (Edinb). 2018 Jul;111:147-153. Epub 2018 Jun 12. doi: 10.1016/j.tube.2018.06.005
  102. Petrosillo N. Tackling the recurrence of Clostridium difficile infection. Med Mal Infect. 2018 Feb;48(1):18-22. Epub 2018 Jan 12. doi: 10.1016/j.medmal.2017.10.007
  103. Petruccioli E, Chiacchio T, Vanini V, Cuzzi G, Codecasa LR, Ferrarese M, Schininà V, Palmieri F, Ippolito G, Goletti D. Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection. Sci Rep. 2018 Oct 23;8(1):15626. doi: 10.1038/s41598-018-33825-w
  104. Piacentini Md, Baiocchini A, Del Nonno F, Melino G, Barlev NA, Rossin F, D’Eletto M, Falasca L. Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2. Cell Death Dis. 2018 Feb 15;9(3):257. doi: 10.1038/s41419-018-0292-8
  105. Pontarelli A, Marchese V, Scolari C, Capone S, El-Hamad I, Donato F, Moioli R, Girardi E, Cirillo DM, Castelli F, Matteelli A. Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis. Travel Med Infect Dis. 2018 Oct 19. pii: S1477-8939(18)30370-3. [Epub ahead of print] doi: 10.1016/j.tmaid.2018.10.015
  106. Pouga L, Santoro MM, Charpentier C, Di Carlo D, Romeo I, Artese A, Alcaro S, Antinori A, Wirden M, Perno CF, Ambrosio FA, Calvez V, Descamps D, Marcelin AG, Ceccherini-Silberstein F, Lambert-Niclot S. New Resistance Mutations to Nucleoside Reverse Transcriptase Inhibitors at Codon 184 of HIV-1 Reverse Transcriptase (M184L and M184T). Chem Biol Drug Des. 2018 Aug 13. [Epub ahead of print] doi: 10.1111/cbdd.13378
  107. Puro V, Fusco FM, Castilletti C, Carletti F, Colavita F, Agrati C, Di Caro A, Capobianchi MR, Ippolito G. Occupational transmission of an Orthopoxvirus infection during an outbreak in a colony of Macaca tonkeana in Lazio Region, Italy, 2015. Zoonoses Public Health. 2018 Aug;65(5):578-583. Epub 2018 Mar 7. doi: 10.1111/zph.12459
  108. Refolo G, Ciccosanti F, Di Rienzo M, Perdomo AB, Romani M, Alonzi T, Tripodi Md, Ippolito G, Piacentini Md, Fimia GMd. Negative regulation of MAVS-mediated antiviral signaling by the mitochondrial protein LRPPRC during HCV infection. Hepatology. 2018 Aug 2. [Epub ahead of print] doi: 10.1002/hep.30149
  109. Regine V, Dorrucci M, Pezzotti P, Mammone A, Quinten C, Pharris A, Suligoi B; The Regional Representatives Of The National Hiv Surveillance System. People living with undiagnosed HIV infection and a low CD4 count: estimates from surveillance data, Italy, 2012 to 2014. Euro Surveill. 2018 Apr;23(15). doi: 10.2807/1560-7917.ES.2018.23.15.17-00240
  110. Reusken CB, Mögling R, Smit PW, Grunow R, Ippolito G, Di Caro A, Koopmans M. Status, quality and specific needs of Ebola virus diagnostic capacity and capability in laboratories of the two European preparedness laboratory networks EMERGE and EVD-LabNet. Euro Surveill. 2018 May;23(19). doi: 10.2807/1560-7917.ES.2018.23.19.17-00404
  111. Robert-Gangneux F, Meroni V, Dupont D, Botterel F, Garcia JMA, Brenier-Pinchart MP, Accoceberry I, Akan H, Abbate I, Boggian K, Bruschi F, Carratalà J, David M, Drgona L, Djurković-Djaković O, Farinas MC, Genco F, Gkrania-Klotsas E, Groll AH, Guy E, Hirzel C, Khanna N, Kurt Ö, Junie LM, Lazzarotto T, Len O, Mueller NJ, Munoz P, Pana ZD, Roilides E, Stajner T, van Delden C, Villena I, Pelloux H, Manuel O. Toxoplasmosis in Transplant Recipients, Europe, 2010-2014. Emerg Infect Dis. 2018 Aug;24(8):1497-1504. doi: 10.3201/eid2408.180045
  112. Romagnoli A, Petruccioli E, Palucci I, Camassa S, Carata E, Petrone L, Mariano S, Sali M, Dini L, Girardi E, Delogu G, Goletti D, Fimia GMd. Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy. Cell Death Dis. 2018 May 24;9(6):624. doi: 10.1038/s41419-018-0640-8
  113. Romette JL, Prat CM, Gould EA, de Lamballerie X, Charrel R, Coutard B, Fooks AR, Bardsley M, Carroll M, Drosten C, Drexler JF, Günther S, Klempa B, Pinschewer D, Klimkait T, Avsic-Zupanc T, Capobianchi MR, Di Caro A, Ippolito G, Nitsche A, Koopmans M, Reusken C, Gorbalenya A, Raoul H, Bourhy H, Mettenleiter T, Reiche S, Batten C, Sabeta C, Paweska JT, Eropkin M, Zverev V, Hu Z, Mac Cullough S, Mirazimi A, Pradel F, Lieutaud P. The European Virus Archive goes global: A growing resource for research. Antiviral Res. 2018 Jul 29;158:127-134. [Epub ahead of print] doi: 10.1016/j.antiviral.2018.07.017
  114. Rossi L, Battistelli C, de Turris V, Noce V, Zwergel C, Valente S, Moioli A, Manzione A, Palladino M, Bordoni V, Domenici A, Menè P, Mai A, Tripodi Md, Strippoli Rd. HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal. Sci Rep. 2018 May 31;8(1):8492. doi: 10.1038/s41598-018-26319-2
  115. Rossin F, Villella VR, D’Eletto M, Farrace MG, Esposito S, Ferrari E, Monzani R, Occhigrossi L, Pagliarini V, Sette C, Cozza G, Barlev NA, Falasca L, Fimia GMd, Kroemer G, Raia V, Maiuri L, Piacentini Md. TG2 regulates the heat-shock response by the post-translational modification of HSF1. EMBO Rep. 2018 Jul;19(7). pii: e45067. Epub 2018 May 11. doi: 10.15252/embr.201745067
  116. Sacchi A, Tumino N, Grassi G, Casetti R, Cimini E, Bordoni V, Ammassari A, Antinori A, Agrati C. A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometry. PLoS One. 2018 Aug 30;13(8):e0202920. eCollection 2018. doi: 10.1371/journal.pone.0202920
  117. Sacchi A, Tumino N, Sabatini A, Cimini E, Casetti R, Bordoni V, Grassi G, Agrati C. Myeloid-Derived Suppressor Cells Specifically Suppress IFN-γ Production and Antitumor Cytotoxic Activity of Vδ2 T Cells. Front Immunol. 2018 Jun 6;9:1271. eCollection 2018. doi: 10.3389/fimmu.2018.01271
  118. Sali M, Buonsenso D, D’Alfonso P, De Maio F, Ceccarelli M, Battah B, Palucci I, Chiacchio T, Goletti D, Sanguinetti M, Valentini P, Delogu G. Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children. J Infect. 2018 Dec;77(6):526-533. Epub 2018 Sep 26. doi: 10.1016/j.jinf.2018.09.011
  119. Sané Schepisi M, Motta I, Dore S, Costa C, Sotgiu G, Girardi E. Tuberculosis transmission among children and adolescents in schools and other congregate settings: a systematic review. New Microbiol. 2018 Oct;41(4):282-290. Epub 2018 Sep 25.
  120. Sane Schepisi M, Navarra A, Altet Gomez MN, Dudnyk A, Dyrhol-Riise AM, Esteban J, Giorgetti PF, Gualano G, Guglielmetti L, Heyckendorf J, Kaluzhenina A, Lange B, Lange C, Manika K, Miah J, Nanovic Z, Pontali E, Prego MR, Solovic I, Tiberi S, Palmieri F, Girardi E. Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study. Open Forum Infect Dis. 2018 Dec 19;6(1):ofy337. eCollection 2019 Jan. doi: 10.1093/ofid/ofy337
  121. Santangelo L, Bordoni V, Montaldo C, Cimini E, Zingoni A, Battistelli C, D’Offizi G, Capobianchi MR, Santoni A, Tripodi Md, Agrati C. Hepatitis C virus direct-acting antivirals therapy impacts on extracellular vesicles microRNAs content and on their immunomodulating properties. Liver Int. 2018 Oct;38(10):1741-1750. Epub 2018 Feb 24. doi: 10.1111/liv.13700
  122. Santoro MM, Di Carlo D, Armenia D, Zaccarelli M, Pinnetti C, Colafigli M, Prati F, Boschi A, Antoni AMD, Lagi F, Sighinolfi L, Gervasoni C, Andreoni M, Antinori A, Mussini C, Perno CF, Borghi V, Sterrantino G. Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >10.3851/IMP3197500,000 copies/ml in clinical practice. Antivir Ther. 2018;23(3):249-257. doi: 10.3851/IMP3197
  123. Santos VS, Goletti D, Kontogianni K, Adams ER, Molina-Moya B, Dominguez J, Crudu V, Martins-Filho PRS, Ruhwald M, Lawson L, Bimba JS, Garcia-Bastero AL, Petrone L, Kabeer BS, Reither K, Cuevas LE. Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: a systematic and meta-analysis. Clin Microbiol Infect. 2018 Aug 1. pii: S1198-743X(18)30535-4. [Epub ahead of print] doi: 10.1016/j.cmi.2018.07.017
  124. Saracino A, Cozzi-Lepri A, Shanyinde M, Ceccherini Silberstein F, Nozza S, Di Biagio A, Cassola G, Bruno G, Capobianchi M, Puoti M, Monno L, d’Arminio Monforte A; ICONA Foundation Study. HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients. PLoS One. 2018 Jan 11;13(1):e0190302. eCollection 2018. doi: 10.1371/journal.pone.0190302
  125. Saracino A, Zaccarelli M, Lorenzini P, Bandera A, Marchetti G, Castelli F, Gori A, Girardi E, Mussini C, Bonfanti P, Ammassari A, d’Arminio Monforte A; Icona Foundation Study Group. Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy. BMC Public Health. 2018 Jul 13;18(1):870. doi: 10.1186/s12889-018-5804-z
  126. Schininà V, Albarello F, Cristofaro M, Di Stefano F, Fusco N, Cuzzi G, Arend SM, Goletti D, Busi Rizzi E. Diagnostic imaging of hepatic tuberculosis: case series. Int J Tuberc Lung Dis. 2018 Jul 1;22(7):779-787. doi: 10.5588/ijtld.17.0710
  127. Scognamiglio P, Chiaradia G, Giovanetti M, Albertini E, Camposeragna A, Farinella M, Lorenzetti D, Oldrini M, Rancilio L, Caraglia A, Maraglino FP, Ippolito G, Girardi E. HIV rapid testing in community and outreach sites: results of a nationwide demonstration project in Italy. BMC Public Health. 2018 Jun 18;18(1):748. doi: 10.1186/s12889-018-5680-6
  128. Soulie C, Santoro MM, Charpentier C, Storto A, Paraskevis D, Di Carlo D, Gennari W, Sterrantino G, Zazzi M, Perno CFd, Calvez V, Descamps D, Ceccherini-Silberstein F, Marcelin AG. Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients. J Antimicrob Chemother. 2018 Nov 23. [Epub ahead of print] doi: 10.1093/jac/dky464
  129. Spertilli Raffaelli C, Rossetti B, Paglicci L, Colafigli M, Punzi G, Borghi V, Pecorari M, Santoro MM, Penco G, Antinori A, Zazzi M, De Luca A, Zanelli G. Impact of transmitted HIV-1 drug resistance on the efficacy of first-line antiretroviral therapy with two nucleos(t)ide reverse transcriptase inhibitors plus an integrase inhibitor or a protease inhibitor. J Antimicrob Chemother. 2018 Sep 1;73(9):2480-2484. doi: 10.1093/jac/dky211
  130. Stallmach A, Anttila VJ, Hell M, Gwynn S, Merino-Amador P, Petrosillo N, Ráčil Z, Warren T, Wenisch C, Wilcox M. Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals. Z Gastroenterol. 2018 Feb 9. [Epub ahead of print] doi: 10.1055/s-0044-100045
  131. Taborelli M, Piselli P, Ettorre GM, Baccarani U, Burra P, Lauro A, Galatioto L, Rendina M, Shalaby S, Petrara R, Nudo F, Toti L, Fantola G, Cimaglia C, Agresta A, Vennarecci G, Pinna AD, Gruttadauria S, Risaliti A, Di Leo A, Rossi M, Tisone G, Zamboni F, Serraino D; Italian Transplant & Cancer Cohort Study. Survival after the diagnosis of de novo malignancy in liver transplant recipients. Int J Cancer. 2018 Aug 9. [Epub ahead of print] doi: 10.1002/ijc.31782
  132. Taborelli M, Piselli P, Ettorre GM, Lauro A, Galatioto L, Baccarani U, Rendina M, Shalaby S, Petrara R, Nudo F, Toti L, Sforza D, Fantola G, Cimaglia C, Agresta A, Vennarecci G, Pinna AD, Gruttadauria S, Risaliti A, Di Leo A, Burra P, Rossi M, Tisone G, Zamboni F, Serraino D; Italian Transplant & Cancer Cohort Study. Risk for virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014. Int J Cancer. 2018 Apr 25. [Epub ahead of print] doi: 10.1002/ijc.31552
  133. Taramasso L, Di Biagio A, Bovis F, Nicolini LA, Antinori A, Milazzo L, Sollima S, Gubertini G, Niero F, Saracino A, Bruno R, Borghi V, Montagnani F, Cattelan A, Hasson H, Taliani G, D’Arminio Monforte A, Mastroianni C, Di Perri G, Bigoni S, Puoti M, Spinetti A, Gori A, Boffa N, Cacopardo B, Giacometti A, Parruti G, Vullo V, Chirianni A, Teti E, Pasquazzi C, Segala D, Andreoni M. Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients. PLoS One. 2018 Feb 20;13(2):e0192627. eCollection 2018. doi: 10.1371/journal.pone.0192627
  134. Taramasso L, Di Biagio A, Maggiolo F, Tavelli A, Lo Caputo S, Bonora S, Zaccarelli M, Caramello P, Costantini A, Viscoli C, d’Arminio Monforte A, Cozzi-Lepri A; Italian Cohort Naive Antiretrovirals (ICONA) Foundation Study Group. First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison. HIV Med. 2018;19(7):475-484 doi: 10.1111/hiv.12628
  135. Tempestilli M, Ammassari A, D’Avolio A, Cicalini S, Gallo AL, Fazio S, Antinori A, Pucillo LP. Development and validation of an HPLC-UV method for quantification of elvitegravir and others new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV-positive patients. Biomed Chromatogr. 2018 May 4:e4274. [Epub ahead of print] doi: 10.1002/bmc.4274
  136. Tiberi S, du Plessis N, Walzl G, Vjecha MJ, Rao M, Ntoumi F, Mfinanga S, Kapata N, Mwaba P, McHugh TD, Ippolito G, Migliori GB, Maeurer MJ, Zumla A. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. Lancet Infect Dis. 2018 Jul;18(7):e183-e198. Epub 2018 Mar 23. Erratum in: Lancet Infect Dis. 2018 Apr 27 doi: 10.1016/S1473-3099(18)30110-5
  137. Tiberi S, Petersen E, Maeurer M, Ntoumi F, Yeboa-Manu D, Mwaba P, Vilaplana C, Dar O, Bates M, Corrah T, Rao M, Kapata N, Azhar EI, Memish ZA, Mfinanga S, Aseffa A, Ippolito G, Migliori GB, Zumla A. Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 – “Wanted: Leaders for a TB-Free World. You can make history. End TB”. Int J Infect Dis. 2018 Mar; 68:122-124. Epub 2018 Mar 22. doi: 10.1016/j.ijid.2018.03.002
  138. Trunfio M, Pinnetti C, Focà E, Bai F, Maffongelli G, Celani L, Cinque P, Celotti A, Andreoni M, Monforte AD, D’Ettorre G, Antinori A, Calcagno A. Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions? AIDS. 2018 Nov 27. [Epub ahead of print] doi: 10.1097/QAD.0000000000002091
  139. Tumbarello M, Trecarichi EM, Corona A, De Rosa FG, Bassetti M, Mussini C, Menichetti F, Viscoli C, Campoli C, Venditti M, De Gasperi A, Mularoni A, Tascini C, Parruti G, Pallotto C, Sica S, Concia E, Cultrera R, De Pascale G, Capone A, Antinori S, Corcione S, Righi E, Losito AR, Digaetano M, Amadori F, Giacobbe DR, Ceccarelli G, Mazza E, Raffaelli F, Spanu T, Cauda R, Viale P. Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae. Clin Infect Dis. 2018 Jun 9. [Epub ahead of print] doi: 10.1093/cid/ciy492
  140. Vairo F, Di Pietrantonj C, Pasqualini C, Mammone A, Lanini S, Nicastri E, Castilletti C, Ferraro F, Di Bari V, Puro V, Scognamiglio P, Di Caro A, Capobianchi MR, Ippolito G. The Surveillance of Chikungunya Virus in a Temperate Climate: Challenges and Possible Solutions from the Experience of Lazio Region, Italy. Viruses. 2018 Sep 14;10(9). pii: E501. doi: 10.3390/v10090501
  141. Vairo F, Mammone A, Lanini S, Nicastri E, Castilletti C, Carletti F, Puro V, Di Lallo D, Panella V, Varrenti D, Scaramozzino P, Di Caro A, Scognamiglio P, Capobianchi MR, Ippolito G; Chikungunya Lazio Outbreak Group. Local transmission of chikungunya in Rome and the Lazio region, Italy. PLoS One. 2018 Dec 21;13(12):e0208896. eCollection 2018. doi: 10.1371/journal.pone.0208896
  142. Venditti C, Vulcano A, D’Arezzo S, Gruber CEM, Selleri M, Antonini M, Lanini S, Marani A, Puro V, Nisii C, Di Caro A. Epidemiological investigation of an Acinetobacter baumannii outbreak using Core Genome Multilocus Sequence Typing. J Glob Antimicrob Resist. 2018 Dec 13. pii: S2213-7165(18)30244-3. [Epub ahead of print] doi: 10.1016/j.jgar.2018.11.027
  143. Vergori A, Garbuglia AR, Piselli P, Del Nonno F, Sias C, Lupi F, Lapa D, Baiocchini A, Cimaglia C, Gentile M, Antinori A, Capobianchi M, Ammassari A. Oral human Papillomavirus DNA detection in HIV-positive men: prevalence, predictors, and co-occurrence at anal site. BMC Infect Dis. 2018 Jan 8;18(1):25. doi: 10.1186/s12879-017-2937-0
  144. Vespasiani-Gentilucci U, Dell’Unto C, De Vincentis A, Baiocchini A, Delle Monache M, Cecere R, Pellicelli AM, Giannelli V, Carotti S, Galati G, Gallo P, Valentini F, Del Nonno F, Rosati D, Morini S, Antonelli-Incalzi R, Picardi A. Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study. Can J Gastroenterol Hepatol. 2018 Mar 14;2018:7564835. eCollection 2018. doi: 10.1155/2018/7564835
  145. Villella VR, Venerando A, Cozza G, Esposito S, Ferrari E, Monzani R, Spinella MC, Oikonomou V, Renga G, Tosco A, Rossin F, Guido S, Silano M, Garaci E, Chao YK, Grimm C, Luciani A, Romani L, Piacentini Md, Raia V, Kroemer G, Maiuri L. A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease. EMBO J. 2018 Nov 29. pii: e100101. [Epub ahead of print] doi: 10.15252/embj.2018100101
  146. Visco-Comandini U, Lapa D, Lionetti R, Taibi C, Loiacono L, Montalbano M, Capobianchi MR, D’Offizi G, Garbuglia AR. Significance of detectable HCV RNA below the limit of quantification in patients treated with DAAs using standard and ultrasensitive protocols. J Med Virol. 2018 Jul; 90(7):1264-1271. Epub 2018 Apr 26. doi: 10.1002/jmv.25084
  147. Vourli G, Pharris A, Cazein F, Costagliola D, Dabis F, Del Amo J, Delpech V, Díaz A, Girardi E, Gourlay A, Gunsenheimer-Bartmeyer B, Hernando V, Nikolopoulos G, Porter K, Rosińska M, Sabin C, Suligoi B, Supervie V, Wit F, Touloumi G. Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population? AIDS. 2018 Oct 4. [Epub ahead of print] doi: 1097/QAD.0000000000002034
  148. Zingaropoli MA, Iannetta Md, Pontecorvo S, Anzivino E, Prezioso C, Rodio DM, Morreale M, D’Abramo Ad, Oliva A, Lichtner M, Cortese A, Frontoni M, Pietropaolo V, Francia A, Mastroianni CM, Vullo V, Ciardi MR. JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus. Biomed Res Int. 2018 Feb 27;2018:5297980. eCollection 2018. doi: 10.1155/2018/5297980

 

Torna all'inizio dei contenuti